Evidence map›Paper›PMID 27219054›Full record

ArticlePLoS neglected tropical diseases2016

The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS).

Samba O Sow, Khitam Muhsen, Dilruba Nasrin, William C Blackwelder, Yukun Wu, Tamer H Farag, Sandra Panchalingam, Dipika Sur, Anita K M Zaidi, Abu S G Faruque and 39 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 166 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
166citing papers in PubMed, 5 pooled it
27.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

166 citing papers in PubMed, 5 syntheses or guidelines pooled it, 258 citations in OpenAlex.

  1. Pooled it
  2. WaterborneJournal of water and health · 2024
    Pooled it
  3. The global prevalence ofParasitology · 2022
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. From conventional to biosensor-based detection ofFood and waterborne parasitology · 2026
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Early life infection withGut microbes · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

106 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

49 authors at 17 institutions in 13 countries.

Samba O SowCentre pour le Développement des Vaccins, Bamako, Mali.
Khitam MuhsenCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Dilruba NasrinCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
William C BlackwelderCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Yukun WuCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Tamer H FaragCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Sandra PanchalingamCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Dipika SurNational Institute of Cholera and Enteric Diseases, Kolkata, India.
Anita K M ZaidiDepartment of Paediatrics and Child Health, the Aga Khan University, Karachi, Pakistan.
Abu S G FaruqueInternational Centre for Diarrhoeal Disease Research, Mohakhali, Dhaka, Bangladesh.
Debasish SahaMedical Research Council (United Kingdom) Unit, Fajara, Gambia.
Richard AdegbolaMedical Research Council (United Kingdom) Unit, Fajara, Gambia.
Pedro L AlonsoCentro de Investigação em Saúde da Manhiça, Maputo, Mozambique.
Robert F BreimanGlobal Disease Detection Division, Kenya Office of the US Centers for Disease Control and Prevention, Nairobi, Kenya.
Quique BassatCentro de Investigação em Saúde da Manhiça, Maputo, Mozambique.
Boubou TambouraCentre pour le Développement des Vaccins, Bamako, Mali.
Doh SanogoCentre pour le Développement des Vaccins, Bamako, Mali.
Uma OnwuchekwaCentre pour le Développement des Vaccins, Bamako, Mali.
Byomkesh MannaNational Institute of Cholera and Enteric Diseases, Kolkata, India.
Thandavarayan RamamurthyNational Institute of Cholera and Enteric Diseases, Kolkata, India.
Suman KanungoNational Institute of Cholera and Enteric Diseases, Kolkata, India.
Shahnawaz AhmedInternational Centre for Diarrhoeal Disease Research, Mohakhali, Dhaka, Bangladesh.
Shahida QureshiDepartment of Paediatrics and Child Health, the Aga Khan University, Karachi, Pakistan.
Farheen QuadriDepartment of Paediatrics and Child Health, the Aga Khan University, Karachi, Pakistan.
Anowar HossainInternational Centre for Diarrhoeal Disease Research, Mohakhali, Dhaka, Bangladesh.
Sumon K DasInternational Centre for Diarrhoeal Disease Research, Mohakhali, Dhaka, Bangladesh.
Martin AntonioMedical Research Council (United Kingdom) Unit, Fajara, Gambia.
M Jahangir HossainMedical Research Council (United Kingdom) Unit, Fajara, Gambia.
Inacio MandomandoCentro de Investigação em Saúde da Manhiça, Maputo, Mozambique.
Tacilta NhampossaCentro de Investigação em Saúde da Manhiça, Maputo, Mozambique.
Sozinho AcácioCentro de Investigação em Saúde da Manhiça, Maputo, Mozambique.
Richard OmoreKenya Medical Research Institute/Centers for Disease Control and Prevention, Kisumu, Kenya.
Joseph O OundoKenya Medical Research Institute/Centers for Disease Control and Prevention, Kisumu, Kenya.
John B OchiengKenya Medical Research Institute/Centers for Disease Control and Prevention, Kisumu, Kenya.
Eric D MintzDivision of Foodborne, Waterborne and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Ciara E O'ReillyDivision of Foodborne, Waterborne and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Lynette Y BerkeleyCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Sofie LivioCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Sharon M TennantCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Halvor SommerfeltCentre of Intervention Science in Maternal and Child Health, Centre for International Health, University of Bergen, Bergen, and Department of International Public Health, Norwegian Institute of Public Health, Oslo, Norway.
James P NataroCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Tomer Ziv-BaranDepartment of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
Roy M Robins-BrowneDepartment of Microbiology and Immunology, The University of Melbourne, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Vladimir MishcherkinCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Jixian ZhangDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, United States of America.
Jie LiuDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, United States of America.
Eric R HouptDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, United States of America.
Karen L KotloffCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Myron M LevineCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
University of Maryland, Baltimore · USCentre Pour le Développement des Vaccins-Mali · MLInternational Centre for Diarrhoeal Disease Research · BDMedical Research Council · GBNational Institute of Cholera and Enteric Diseases · INAga Khan University · PKCenters for Disease Control and Prevention · KEInstituto Nacional de Saúde · MZUniversity of Virginia · USCenters for Disease Control and Prevention · USBarcelona Institute for Global Health · ESEmergent BioSolutions (United States) · USKenya Medical Research Institute · KEManhiça Health Research Centre · MZMurdoch Children's Research Institute · AUNorwegian Institute of Public Health · NOTel Aviv University · IL

Funding

Medical Research Council MC_U190074190Medical Research Council MC_U190081991Medical Research Council MC_UP_A900_1122
6 · The paper itself

Abstract

backgroundThe importance of Cryptosporidium as a pediatric enteropathogen in developing countries is recognized.

methodsData from the Global Enteric Multicenter Study (GEMS), a 3-year, 7-site, case-control study of moderate-to-severe diarrhea (MSD) and GEMS-1A (1-year study of MSD and less-severe diarrhea [LSD]) were analyzed. Stools from 12,110 MSD and 3,174 LSD cases among children aged <60 months and from 21,527 randomly-selected controls matched by age, sex and community were immunoassay-tested for Cryptosporidium. Species of a subset of Cryptosporidium-positive specimens were identified by PCR; GP60 sequencing identified anthroponotic C. parvum. Combined annual Cryptosporidium-attributable diarrhea incidences among children aged <24 months for African and Asian GEMS sites were extrapolated to sub-Saharan Africa and South Asian regions to estimate region-wide MSD and LSD burdens. Attributable and excess mortality due to Cryptosporidium diarrhea were estimated.

findingsCryptosporidium was significantly associated with MSD and LSD below age 24 months. Among Cryptosporidium-positive MSD cases, C. hominis was detected in 77.8% (95% CI, 73.0%-81.9%) and C. parvum in 9.9% (95% CI, 7.1%-13.6%); 92% of C. parvum tested were anthroponotic genotypes. Annual Cryptosporidium-attributable MSD incidence was 3.48 (95% CI, 2.27-4.67) and 3.18 (95% CI, 1.85-4.52) per 100 child-years in African and Asian infants, respectively, and 1.41 (95% CI, 0.73-2.08) and 1.36 (95% CI, 0.66-2.05) per 100 child-years in toddlers. Corresponding Cryptosporidium-attributable LSD incidences per 100 child-years were 2.52 (95% CI, 0.33-5.01) and 4.88 (95% CI, 0.82-8.92) in infants and 4.04 (95% CI, 0.56-7.51) and 4.71 (95% CI, 0.24-9.18) in toddlers. We estimate 2.9 and 4.7 million Cryptosporidium-attributable cases annually in children aged <24 months in the sub-Saharan Africa and India/Pakistan/Bangladesh/Nepal/Afghanistan regions, respectively, and ~202,000 Cryptosporidium-attributable deaths (regions combined). ~59,000 excess deaths occurred among Cryptosporidium-attributable diarrhea cases over expected if cases had been Cryptosporidium-negative.

conclusionsThe enormous African/Asian Cryptosporidium disease burden warrants investments to develop vaccines, diagnostics and therapies.

Indexed as

Cost of IllnessAfghanistanAfrica South of the SaharaAsiaCase-Control StudiesChild, PreschoolCryptosporidiosisCryptosporidiumData MiningDeveloping CountriesDiarrheaFecesFemaleGastrointestinal DiseasesHumansImmunoassay

Identifiers

PMID27219054
PMCPMC4878811
OpenAlexW2399861846

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.